AGEX THERAPEUTICS, INC.

Profile

Company Names

AGEX THERAPEUTICS, INC.

Addresses

1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA, CA 94501

Phone Numbers

510-521-3390

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$19,012,500.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2019-03-11 
$4,500,000.00 
$5,000,000.00 
$500,000.00 
Equity 
4
2018-08-15 
$200,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2018-06-06 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
2
2018-01-16 
$462,500.00 
$1,000,000.00 
$537,500.00 
Equity 
1
2017-06-23 
$8,850,000.00 
$10,000,000.00 
$1,150,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GREGORY 
 
BAILEY 
DIRECTOR
REGISTERPATIENT.COM, INC.   |  INGAGEPATIENT, INC.   |  SALVARX GROUP PLC   |  DENIM LABS, INC.   |  JUVENESCENCE LTD   |  LYGENESIS INC.   |  AGEX THERAPEUTICS, INC.   |  DENIM SOFTWARE, INC.   |  SABR HOLDINGS LTD   |  CHELSEA AVONDALE GROUP LTD.   |  PORTAGE BIOTECH INC.   |  ALPHATON CAPITAL CORP
NOT APPLICABLE 
 
BIOTIME, INC. 
PROMOTER
AGEX THERAPEUTICS, INC.
ANNALISA 
 
JENKINS 
DIRECTOR
PROSENSA HOLDING N.V.   |  BIOTHERA HOLDING CORP.   |  DIMENSION THERAPEUTICS, INC.   |  ARDELYX, INC.   |  ONCOSEC MEDICAL INC   |  VIUM, INC.   |  AGEX THERAPEUTICS, INC.   |  COCOON BIOTECH INC.   |  SKYE BIOSCIENCE, INC.   |  ETIRARX, INC.
ALFRED 
D. 
KINGSLEY 
DIRECTOR, EXECUTIVE OFFICER
ONCOCYTE CORP   |  ASCENDANCE BIOTECHNOLOGY, INC.   |  AGEX THERAPEUTICS, INC.
JOHN 
 
MAULDIN 
DIRECTOR
AGEX THERAPEUTICS, INC.
JOHN 
F. 
MAULDIN 
DIRECTOR
AGEX THERAPEUTICS, INC.
MICHAEL 
H. 
MULROY 
DIRECTOR
COMARCO INC   |  AGEX THERAPEUTICS, INC.
RUSSELL 
 
SKIBSTED 
EXECUTIVE OFFICER
AEOLUS PHARMACEUTICALS, INC.   |  ONCOCYTE CORP   |  AGEX THERAPEUTICS, INC.   |  ALIMERA SCIENCES INC
MICHAEL 
D. 
WEST 
EXECUTIVE OFFICER, DIRECTOR
ASCENDANCE BIOTECHNOLOGY, INC.   |  AGEX THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-03-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-03-11 
2018-08-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-08-15 
2018-06-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-06-06 
2018-01-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-16 
2017-07-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#